PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.624
EU - Europa 2.093
AS - Asia 1.904
AF - Africa 346
SA - Sud America 308
Continente sconosciuto - Info sul continente non disponibili 143
OC - Oceania 3
Totale 8.421
Nazione #
US - Stati Uniti d'America 3.506
SG - Singapore 891
IT - Italia 723
RU - Federazione Russa 644
CN - Cina 511
BR - Brasile 248
IE - Irlanda 202
CI - Costa d'Avorio 184
VN - Vietnam 162
UA - Ucraina 91
KR - Corea 88
FR - Francia 84
DE - Germania 82
SN - Senegal 70
CA - Canada 68
GB - Regno Unito 60
SE - Svezia 56
IN - India 48
NG - Nigeria 41
BD - Bangladesh 38
HK - Hong Kong 30
MX - Messico 29
JP - Giappone 28
PL - Polonia 28
FI - Finlandia 26
NL - Olanda 24
AR - Argentina 19
ZA - Sudafrica 19
ES - Italia 16
TR - Turchia 16
IQ - Iraq 15
PK - Pakistan 13
ID - Indonesia 10
EC - Ecuador 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
BJ - Benin 8
CO - Colombia 8
LT - Lituania 8
CH - Svizzera 6
CL - Cile 6
CZ - Repubblica Ceca 6
VE - Venezuela 6
AT - Austria 5
GR - Grecia 5
MA - Marocco 5
NP - Nepal 5
PY - Paraguay 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
EU - Europa 4
GT - Guatemala 4
HR - Croazia 4
LB - Libano 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
JO - Giordania 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
EG - Egitto 2
GD - Grenada 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
Totale 8.281
Città #
Singapore 560
Santa Clara 471
Dallas 437
Chandler 321
San Jose 281
Moscow 275
Ashburn 218
Dublin 202
Catania 186
Abidjan 184
Chicago 168
Hefei 128
Houston 96
Jacksonville 96
Beijing 87
Seoul 85
Boardman 83
Los Angeles 74
Dakar 70
Lauterbourg 61
New York 55
Ho Chi Minh City 54
Cambridge 48
Lawrence 47
Andover 43
Council Bluffs 39
Hanoi 39
Civitanova Marche 35
Rome 33
Orem 31
Palermo 31
São Paulo 31
Wilmington 28
Toronto 27
Hong Kong 26
Buffalo 25
Des Moines 24
Nanjing 23
Tokyo 23
Abuja 22
Bremen 21
Seattle 20
Warsaw 19
Atlanta 18
Phoenix 18
The Dalles 18
Columbus 17
Milan 17
Montreal 17
Aci Catena 16
Falls Church 16
Lagos 16
Messina 16
Brooklyn 15
Rio de Janeiro 15
Johannesburg 13
Munich 13
Lappeenranta 12
Stockholm 12
Redwood City 11
Boydton 10
Changsha 10
Denver 10
Dong Ket 10
Hebei 10
Manchester 10
Mexico City 10
Mumbai 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Belo Horizonte 9
City of London 9
Naples 9
San Mateo 9
Amsterdam 8
Cotonou 8
Grafing 8
London 8
Nairobi 8
Redmond 8
Redondo Beach 8
Washington 8
Ankara 7
Cagliari 7
Chennai 7
Frankfurt am Main 7
Jiaxing 7
Nanchang 7
San Francisco 7
San Gregorio di Catania 7
Baghdad 6
Boston 6
Brasília 6
Charlotte 6
Dearborn 6
Guangzhou 6
Pozzallo 6
Rosolini 6
Shanghai 6
Totale 5.407
Nome #
Current drug treatments targeting dopamine D3 receptor 249
Antioxidant and osmoprotecting activity of taurine in dry eye models 198
Caffeine Protects Against Retinal Inflammation 186
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 183
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 168
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 167
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 166
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 164
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 162
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 161
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 160
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 160
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 158
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 156
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 143
Controversies in Glaucoma: Current Medical Treatment and Drug Development 142
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 142
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 142
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 138
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 136
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 135
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 134
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 134
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 132
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 132
Ocular pharmacological profile of hydrocortisone in dry eye disease 131
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 130
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 130
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 129
Retinal protection and distribution of curcumin in vitro and in vivo 129
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 128
Novel therapeutics in glaucoma management 127
P2X7 receptor antagonism: implications in diabetic retinopathy 123
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 121
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 121
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 121
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 120
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 120
Do extracellular RNAs provide insight into uveal melanoma biology? 119
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 118
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 117
Integrating network pharmacology: The next-generation approach in ocular drug discovery 116
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 116
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 115
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 106
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 106
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 103
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 102
Small molecules to treat angiogenesis and inflammation in an in-vitro model of diabetic retinopathy 101
In-Silico Characterization of von Willebrand Factor Bound to FVIII 99
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 99
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 97
Characterization of protein-protein interfaces through a protein contact network approach 94
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 94
MicroRNA target prediction in glaucoma 92
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 92
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 88
Ocular allergy 84
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 83
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 82
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 80
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 78
The P2X7 receptor as a new pharmacological target for retinal diseases 74
Ocular Allergies 67
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 67
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 66
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 65
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 52
Retinal alterations resemble brain pathology in a rat model of Parkinson’s disease induced by intranigral infusion of α-synuclein oligomers 27
Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools 24
Safety and effectiveness of vital dyes for intraocular surgery 20
Totale 8.421
Categoria #
all - tutte 26.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 0 45 10 6 50 18 64 21 32 6 19 83
2022/2023927 61 66 17 109 121 120 16 170 173 16 31 27
2023/2024403 32 43 18 21 31 115 7 30 1 3 57 45
2024/20251.799 42 258 80 128 378 244 104 57 129 109 155 115
2025/20263.990 251 196 614 252 558 794 416 85 208 274 212 130
2026/2027223 152 71 0 0 0 0 0 0 0 0 0 0
Totale 8.421